Wood Mark 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Apr 23, 2013

Form 4

Period: 2013-04-22

VP, Human Resources

Transactions

Exercise/Conversion
Stock Option (right to buy) Common Stock
2013-04-22−833→ 10,837 total
Exercise: $21.51From: 2010-11-12Exp: 2020-05-11→ Common Stock (833 underlying)
Exercise/Conversion
Common Stock
2013-04-22$26.49/sh+812$21,510→ 25,827 total
Exercise/Conversion
Stock Option (right to buy) Common Stock
2013-04-22−937→ 938 total
Exercise: $14.39From: 2009-11-12Exp: 2019-05-11→ Common Stock (937 underlying)
Exercise/Conversion
Common Stock
2013-04-22$14.39/sh+937$13,483→ 24,182 total
Exercise/Conversion
Common Stock
2013-04-22$21.51/sh+833$17,918→ 25,015 total
Sale
Common Stock
2013-04-22$65.57/sh−3,102$203,413→ 23,245 total
Exercise/Conversion
Common Stock
2013-04-22$37.46/sh+520$19,479→ 26,347 total
Exercise/Conversion
Stock Option (right to buy) Common Stock
2013-04-22−520→ 19,275 total
Exercise: $37.46From: 2012-11-08Exp: 2022-05-07→ Common Stock (520 underlying)
Exercise/Conversion
Stock Option (right to buy)
2013-04-22−812→ 20,317 total
Exercise: $26.49From: 2011-11-12Exp: 2021-05-11→ Common Stock (812 underlying)

Footnotes (7)

[F1]Transaction made pursuant to a Rule 10b5-1 plan executed on August 13, 2012.
[F2]The price in Column 4 is a weighted average price. The prices actually received ranged from $65.01 to $66.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
[F4]Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter. Remarks:
[F5]Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.
[F6]Original option grant vests 6/48th on November 8, 2012 and 1/48th each on the 8th of each month thereafter.
[F7]Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.

Documents

1 file